Literature DB >> 34390103

Type of headache at onset and risk for complications in reversible cerebral vasoconstriction syndrome.

Kristin Sophie Lange1,2,3, Ophélie Forster1, Jérôme Mawet4, Gabrielle Tuloup5, Cécilia Burcin4, Lucas Corti1, Claire Duflos6, Caroline Roos4, Anne Ducros1,7.   

Abstract

BACKGROUND: In a recent Italian study, 30% of patients with reversible cerebral vasoconstriction syndrome (RCVS) presented without thunderclap headache (TCH), and tended to present more severe forms of RCVS than patients with TCH. We aimed to analyze the risk for complications of RCVS in patients with and without TCH at onset.
METHODS: In a pooled cohort of 345 French patients with RCVS, we compared patients with and without TCH at onset regarding rates of neurological complications, and the functional outcome at 3 months.
RESULTS: As compared to the 281 patients with TCH at onset, the 64 patients without TCH had a higher risk for any neurological complication (61% vs. 24%, OR 4.9, 95% CI 2.8-8.7, p < 0.001). The association was strongest for cervical artery dissections (28% vs. 5%, OR 8.1, 95% CI 3.7-17.6, p < 0.001), followed by posterior reversible encephalopathy syndrome (17% vs. 3%, OR 7.1, 95% CI 2.7-18.4, p < 0.001), seizures (9% vs. 2.5%, OR 4.1, 95% CI 1.3-12.5, p = 0.019), and subarachnoid hemorrhage (41% vs. 16%, OR 3.5, 95% CI 1.9-6.3, p < 0.001). In multivariable analysis, the risk for any neurological complication remained significantly elevated in the absence of TCH (OR 3.5, 95% CI 1.8-6.8, p < 0.001). The functional outcome was equal in both groups, with a modified Rankin scale score of 0-1 in ≥90% of patients.
CONCLUSIONS: Absence of TCH at onset might predict a higher risk of complications in RCVS. Our results warrant further multicentric studies to prove this finding.
© 2021 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.

Entities:  

Keywords:  calcitonin gene-related peptide; cerebrovascular diseases; reversible cerebral vasoconstriction syndrome; stroke; thunderclap headache

Mesh:

Year:  2021        PMID: 34390103     DOI: 10.1111/ene.15064

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  2 in total

1.  Eclampsia with RCVS: Postpartum seizure provoked by methergine.

Authors:  Gregory W Kirschen; Katerina Hoyt; Emily Johnson; Silka Patel
Journal:  Pregnancy Hypertens       Date:  2022-01-15       Impact factor: 2.899

Review 2.  Pathophysiology of reversible cerebral vasoconstriction syndrome.

Authors:  Shih-Pin Chen; Shuu-Jiun Wang
Journal:  J Biomed Sci       Date:  2022-09-21       Impact factor: 12.771

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.